Triple

T498808
Position Surface form Disambiguated ID Type / Status
Subject Cambridge Biomedical Campus E10353 entity
Predicate hasMajorFacility P105 FINISHED
Object Cambridge Blood and Stem Cell Biobank
The Cambridge Blood and Stem Cell Biobank is a major research facility that collects, processes, and stores human blood and stem cell samples to support biomedical and translational research.
E62084 NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Cambridge Blood and Stem Cell Biobank | Statement: [Cambridge Biomedical Campus, hasMajorFacility, Cambridge Blood and Stem Cell Biobank]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Cambridge Blood and Stem Cell Biobank
Context triple: [Cambridge Biomedical Campus, hasMajorFacility, Cambridge Blood and Stem Cell Biobank]
  • A. Cambridge Stem Cell Institute
    The Cambridge Stem Cell Institute is a leading research center at the University of Cambridge dedicated to understanding stem cell biology and translating this knowledge into new treatments for human disease.
  • B. NHS Blood and Transplant
    NHS Blood and Transplant is a UK special health authority responsible for providing a safe and reliable supply of blood, organs, and associated services to the National Health Service.
  • C. Center for Cellular and Molecular Therapeutics
    The Center for Cellular and Molecular Therapeutics is a research institute specializing in developing gene and cell-based therapies for pediatric and genetic diseases.
  • D. CRUK Cambridge Institute
    CRUK Cambridge Institute is a leading cancer research center at the University of Cambridge that integrates laboratory science with clinical and computational approaches to improve cancer diagnosis, treatment, and prevention.
  • E. Babraham Research Campus
    Babraham Research Campus is a major life sciences research and innovation hub near Cambridge, England, focused on bioscience, biotechnology, and academic–industry collaboration.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Cambridge Blood and Stem Cell Biobank
Triple: [Cambridge Biomedical Campus, hasMajorFacility, Cambridge Blood and Stem Cell Biobank]
Generated description
The Cambridge Blood and Stem Cell Biobank is a major research facility that collects, processes, and stores human blood and stem cell samples to support biomedical and translational research.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: Cambridge Blood and Stem Cell Biobank
Target entity description: The Cambridge Blood and Stem Cell Biobank is a major research facility that collects, processes, and stores human blood and stem cell samples to support biomedical and translational research.
  • A. Cambridge Stem Cell Institute
    The Cambridge Stem Cell Institute is a leading research center at the University of Cambridge dedicated to understanding stem cell biology and translating this knowledge into new treatments for human disease.
  • B. NHS Blood and Transplant
    NHS Blood and Transplant is a UK special health authority responsible for providing a safe and reliable supply of blood, organs, and associated services to the National Health Service.
  • C. Center for Cellular and Molecular Therapeutics
    The Center for Cellular and Molecular Therapeutics is a research institute specializing in developing gene and cell-based therapies for pediatric and genetic diseases.
  • D. CRUK Cambridge Institute
    CRUK Cambridge Institute is a leading cancer research center at the University of Cambridge that integrates laboratory science with clinical and computational approaches to improve cancer diagnosis, treatment, and prevention.
  • E. Babraham Research Campus
    Babraham Research Campus is a major life sciences research and innovation hub near Cambridge, England, focused on bioscience, biotechnology, and academic–industry collaboration.
  • F. None of above. chosen

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69a2e847df8481909239ec08ccf1e376 completed Feb. 28, 2026, 1:06 p.m.
NER Named-entity recognition batch_69a2f119b14c8190a5a6b119579c2682 completed Feb. 28, 2026, 1:43 p.m.
NED1 Entity disambiguation (via context triple) batch_69a481f1ee28819087e90028b89e877e completed March 1, 2026, 6:14 p.m.
NEDg Description generation batch_69a482749e78819093f8f81090eedfa2 completed March 1, 2026, 6:16 p.m.
NED2 Entity disambiguation (via description) batch_69a483073dcc8190b05f89a81207d3d2 completed March 1, 2026, 6:18 p.m.
Created at: Feb. 28, 2026, 1:12 p.m.